Northern Trust Corp Catalyst Biosciences, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.49 - $1.95 $921 - $3,667	1,881 Added 2.23%	86,412 $44,000
Q2 2022 Aug 12, 2022	BUY	$0.36 - $1.78 $303 - $1,500	843 Added 1.01%	84,531 $150,000
Q1 2022 May 13, 2022	SELL	$0.51 - $1.0 $9,418 - $18,468	-18,468 Reduced 18.08%	83,688 $55,000
Q4 2021 Feb 08, 2022	SELL	$0.91 - $4.16 $1,104 - $5,050	-1,214 Reduced 1.17%	102,156 $93,000
Q3 2021 Nov 15, 2021	SELL	$3.78 - $5.18 $13,505 - $18,508	-3,573 Reduced 3.34%	103,370 $425,000
Q2 2021 Aug 13, 2021	SELL	$4.1 - $5.33 $940,084 - $1.22 Million	-229,289 Reduced 68.19%	106,943 $463,000
Q1 2021 May 12, 2021	BUY	$4.93 - $7.15 $140,815 - $204,225	28,563 Added 9.28%	336,232 $1.69 Million
Q4 2020 Feb 11, 2021	SELL	$4.55 - $7.29 $79,415 - $127,239	-17,454 Reduced 5.37%	307,669 $1.94 Million
Q3 2020 Nov 16, 2020	BUY	$4.22 - $6.04 $152,953 - $218,919	36,245 Added 12.55%	325,123 $1.4 Million
Q2 2020 Aug 14, 2020	BUY	$3.76 - $8.01 $674,122 - $1.44 Million	179,288 Added 163.6%	288,878 $1.7 Million
Q1 2020 May 14, 2020	BUY	$3.5 - $8.51 $21,399 - $52,030	6,114 Added 5.91%	109,590 $479,000
Q4 2019 Feb 14, 2020	BUY	$4.52 - $7.91 $43,586 - $76,276	9,643 Added 10.28%	103,476 $705,000
Q3 2019 Nov 13, 2019	SELL	$4.91 - $9.31 $325,287 - $616,787	-66,250 Reduced 41.38%	93,833 $461,000
Q2 2019 Aug 13, 2019	SELL	$7.08 - $10.6 $39,279 - $58,808	-5,548 Reduced 3.35%	160,083 $1.18 Million
Q1 2019 May 13, 2019	BUY	$7.67 - $9.96 $102,662 - $133,314	13,385 Added 8.79%	165,631 $1.34 Million
Q4 2018 Feb 12, 2019	BUY	$6.59 - $11.28 $109,492 - $187,417	16,615 Added 12.25%	152,246 $1.2 Million
Q3 2018 Nov 14, 2018	BUY	$9.35 - $12.44 $53,622 - $71,343	5,735 Added 4.42%	135,631 $1.46 Million
Q2 2018 Aug 14, 2018	BUY	$9.11 - $28.88 $950,537 - $3.01 Million	104,340 Added 408.28%	129,896 $1.52 Million
Q1 2018 May 09, 2018	BUY	$14.18 - $35.6 $172,684 - $433,536	12,178 Added 91.03%	25,556 $659,000
Q4 2017 Feb 14, 2018	BUY	$4.52 - $13.69 $60,468 - $183,144	13,378	13,378 $183,000

Others Institutions Holding CBIO

# of Institutions

Shares Held

215

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

215
Shares

$0
0.0% of portfolio

View Full List

About CATALYST BIOSCIENCES, INC.

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

More about CBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account